FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
FDA批准摘要:Pirtobrutinib用于治疗复发或难治性套细胞淋巴瘤
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1272
Telaraja, Deepti; Kasamon, Yvette L; Collazo, Justin S; Leong, Ruby; Wang, Kun; Li, Ping; Dahmane, Elyes; Yang, Yuching; Earp, Justin; Grimstein, Manuela; Rodriguez, Lisa R; Theoret, Marc R; Gormley, Nicole J